Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Marlies Wijsenbeek, Arata Azuma et al.|New England Journal of Medicine|2025Cited by 159
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunitiesPaolo Spagnolo, Vincent Cottin, Christopher J. Ryerson et al.|The Lancet Respiratory Medicine|2021Cited by 144
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M. Maher, Fernando J. Martínez, Shervin Assassi et al.|New England Journal of Medicine|2025Cited by 134
Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic DiseaseWim Wuyts, Elisabeth Bendstrup, Marlies Wijsenbeek et al.|Respiration|2019Cited by 93
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical StatementAnna J. Podolanczuk, Christopher J. Ryerson, Gary M. Hunninghake et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 78